Ad
related to: vytorin patent expiration form template list
Search results
Results from the WOW.Com Content Network
[[Category:Patent law templates]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:Patent law templates]]</noinclude> to the end of the template code, making sure it starts on the same line as the code's last character.
The US patent number without commas; for numeric-only values, commas will be inserted by the template. While the USPTO parser ignores commas, other services (notably Google Patents) cannot handle them. For design or reissued patents prefix with D or RE, respectively; see Patent Search Help for the full list. 2 (optional) Link title.
Note that patent application numbers are generally different from patent numbers. If you need this, please use the Template:Cite patent template with the optional application parameter. Examples: {{patent|US|6556992}} results in; US 6556992 {{patent|US|6556992|"Method and system for rating patents and other intangible assets."}} results in
Generic versions were approved in 2017. [2] The combination preparation is marketed by Merck & Co. under the trade names Vytorin in the US and Inegy in the European Union. In 2018, it was the 349th most commonly prescribed medication in the United States, with more than 800 thousand prescriptions.
{{Cite patent}}, creates links to US and other patents on the espacenet database {{Citeref patent}}, for an inline citations to a patent bibliography {{EPO Register}}, to include a link to the European Patent Register entry of a European patent or patent application {}, a generic template for general use referring to world's patent offices
The original patent term under the 1790 Patent Act was decided individually for each patent, but "not exceeding fourteen years". The 1836 Patent Act (5 Stat. 117, 119, 5) provided (in addition to the fourteen-year term) an extension "for the term of seven years from and after the expiration of the first term" in certain circumstances, when the inventor hasn't got "a reasonable remuneration for ...
All in all, Merck showed it is making substantial progress in preparing for 2028’s patent expiration of its blockbuster drug, which will likely dent sales. Besides Winrevair that has been ...
This page was last edited on 9 November 2024, at 14:28 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Ad
related to: vytorin patent expiration form template list